医疗补助管理护理计划对阿片类药物使用障碍治疗质量指标的预测结果
Maureen T Stewart1, Sage R Feltus1, Christina Andrews2
1The Heller School for Social Policy and Management, Brandeis University, USA; Department of Health Law, Policy and Management, Boston University School of Public Health, USA.
Drug and alcohol dependence
|June 7, 2025
概括
国家和医疗补助管理护理计划 (MCP) 政策显著影响阿片类药物使用障碍 (OUD) 治疗. 支持OUD治疗获取的政策,如1115豁免,改善启动和参与,而预先授权布普伦诺芬阻碍了它.
科学领域:
- 医疗保健服务研究 医疗服务研究
- 公共卫生政策 公共卫生政策
- 成 药物 药物 药物 药物
背景情况:
- 医疗补助管理护理计划 (MCP) 和国家对于高质量的阿片类药物使用障碍 (OUD) 治疗机会至关重要.
- 确定提高MCP在OUD治疗中的表现的政策至关重要.
研究的目的:
- 确定MCP与州级政策之间的关联以及OUD治疗质量指标.
- 分析MCP特征和国家政策如何影响OUD治疗的启动和参与.
主要方法:
- 链接了MCP特征 (利状况,合同,市场份额,布诺芬政策) 和州医疗补助政策的公开数据.
- 利用国家质量保证委员会对计划级OUD治疗质量指标的数据 (n=107).
- 使用回归分析来检查与OUD治疗启动和参与率的政策关联.
主要成果:
- 平均OUD治疗启动率为59.6%,参与率为30.9%.
- 拥有较大的市场份额的MCP显示出较低的启动率 (4.66个百分点) 和参与率 (4.54个百分点).
- 在1115个SUD豁免州的计划中,启动率 (7.75个百分比) 和参与率 (8.55个百分比) 较高.
- 布普伦诺芬的先前授权与参与率下降4.53个百分点有关.
结论:
- 国家和MCP政策是改善OUD治疗的启动和持续参与的关键杆.
- 进一步调查具体的政策关系是有必要的,以优化OUD护理的交付.
更多相关视频
相关概念视频
Opioid Analgesics: Synthetic and Semisynthetic Opioids
454
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
454
Analgesia and Pain Management
823
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
823
Opioid Analgesics: Morphine and Other Natural Cogeners
382
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
382
Methods of Documentation VI: Case Management Model
633
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
For example, a patient with a chronic...
633
Opioid Receptors: Overview
2.0K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
2.0K
Drug Abuse and Addiction: Pharmacological Phenomena
676
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
676


